An Observational Real-world Study to Evaluate the Impact of Dermatological Toxicities on the Quality of Life in Patients With Early Breast Cancer Treated With Adjuvant Endocrine Therapy - BCARE (Breast Cancer Adjuvant Real-world Evaluation of Dermatological Adverse Events)

RecruitingOBSERVATIONAL
Enrollment

156

Participants

Timeline

Start Date

November 22, 2024

Primary Completion Date

November 30, 2025

Study Completion Date

March 31, 2026

Conditions
Early Breast CancerSkin ConditionQuality of Life
Trial Locations (9)

31100

RECRUITING

Institut Universitaire du Cancer Toulouse - Oncopole, Toulouse

Unknown

RECRUITING

Institut du Cancer de Montpellier - Val d'Aurelle, Montpellier

RECRUITING

Sygros Hospital, Athens

RECRUITING

Aristotle University of Thessaloniki, Thessaloniki

RECRUITING

Sant'Orsola-Malpighi Hospital University of Bologna, Bologna

RECRUITING

"Clinica Dermatologica dell'Università di Napoli Federico II", Napoli

RECRUITING

Fondazione Policlinico A. Gemelli, Roma

RECRUITING

Hospital Del Mar, Barcelona

RECRUITING

Hospital General de Fuerteventura, Las Palmas

All Listed Sponsors
lead

Pierre Fabre Medicament

INDUSTRY

NCT06690489 - An Observational Real-world Study to Evaluate the Impact of Dermatological Toxicities on the Quality of Life in Patients With Early Breast Cancer Treated With Adjuvant Endocrine Therapy - BCARE (Breast Cancer Adjuvant Real-world Evaluation of Dermatological Adverse Events) | Biotech Hunter | Biotech Hunter